A sweeping review of dozens of clinical trials suggests that today’s most widely used GLP-1 receptor agonist drugs produce broadly consistent weight-loss results across age, race, ethnicity, and ...
Some patients taking popular GLP-1 weight loss drugs may be able to keep the weight off while taking injections less often, ...
In this week’s STATus Report, host Alex Hogan explains why weight loss pills were so much harder to develop than injectables.
Lots of people are talking about peptides. But what are they? Here’s a quick primer on the health trend and what we know about peptides’ safety.
Driven by high prices, lack of insurance, and a desire to lose weight, the proliferation of fake and falsified obesity drugs is prompting public health concern. Sophie Cousins reports.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results